Worrell Laila reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Laila Worrell reported awards of additional restricted stock units tied to prior equity grants. On March 26, 2026, she received 24.05 2024 Annual RSUs, 20.07 2025 Annual RSUs, and 10.99 2025 Elective RSUs, all at a stated price of $0.00 per unit as compensation.
Each RSU represents the right to receive one share of Moelis Class A common stock. These RSUs were issued as dividend equivalents on the related underlying RSU awards and will vest at the same time as those underlying awards. Following these grants, Worrell’s reported holdings in these RSU series are 2,075.39, 1,731.70, and 948.78 units, respectively, with no sales reported in this filing.
Cantor Eric reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Company director and vice chairman Eric Cantor reported compensation-related equity grants rather than market trades. On March 26, he was awarded multiple Incentive RSUs and Long Term Incentive RSUs that function as dividend equivalents on his existing unvested RSU awards.
Each Restricted Stock Unit represents a right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement. These dividend-equivalent RSUs will vest on the same schedule as the underlying Incentive and Long Term Incentive RSUs issued between February 2022 and February 2025, and no open‑market purchases or sales were reported.
Riehl Nick reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co Principal Accounting Officer Nick Riehl reported receiving five small grants of dividend-equivalent Restricted Stock Units (RSUs) tied to existing incentive awards. In total, he was granted 36.8 RSUs that each represent the right to receive either a share of Class A common stock or cash equal to its market value upon settlement.
The RSUs relate to prior Incentive and Long Term Incentive RSUs issued in February 2024 and February 2025, as well as Incentive and Special Incentive RSUs issued in February 2026. These dividend-equivalent RSUs will vest on the same schedule as the underlying unvested RSUs, reflecting routine compensation rather than any open-market stock purchases or sales.
Moelis & Company Chief Financial Officer Christopher Callesano reported routine compensation-related awards of Incentive Restricted Stock Units (RSUs). On March 26, 2026, he acquired 4.5000 2021 Incentive RSUs, 14.1900 2022 Incentive RSUs, 14.6200 2023 Incentive RSUs, and 15.5600 2024 Incentive RSUs, all at a grant price of $0.0000 per unit.
Each RSU represents the right, upon settlement, to receive either one share of Class A common stock or cash equal to its fair market value, at the company’s option. The footnotes explain these Incentive RSUs were issued as dividend equivalents on previously granted unvested Incentive RSUs and will vest on the same schedule as those underlying awards. These are non-market, compensation grants rather than open-market purchases or sales.
Pilcher Ciafone Katherine reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co Chief Operating Officer Katherine Pilcher Ciafone received additional incentive RSUs as part of her equity compensation. On March 26, she was granted 16.48 RSUs linked to 2021 incentives and 46.89 RSUs linked to 2022 incentives, each convertible into an equivalent number of Class A common shares or cash at the company’s option.
The footnotes state these incentive RSUs were issued as dividend equivalents on her existing unvested incentive RSUs granted in February 2022 and February 2023. The dividend-equivalent RSUs will vest on the same schedule as the underlying unvested incentive RSUs, reflecting routine compensation rather than open-market buying or selling.
WATANABE OSAMU R. reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co reported that General Counsel and Secretary Osamu R. Watanabe received additional restricted stock units as compensation. On March 26, 2026, he was granted an aggregate of roughly 275.10 dividend-equivalent Incentive and Special Incentive RSUs, each linked to existing unvested awards.
Each RSU entitles the holder, upon settlement, to either one share of Class A common stock or cash equal to that share’s fair market value, at the company’s option. These grants vest on the same schedule as the underlying unvested Incentive RSUs and represent routine equity-based compensation rather than open-market stock purchases or sales.
Barker Thorold reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Barker Thorold received a grant of 19.11 2025 Annual Restricted Stock Units on Class A Common Stock. The grant was reported at a price of $0.00 per unit as a compensation-related award, not an open-market trade. Following this award, Thorold directly holds 1,649.29 shares, including the new RSUs, which were issued as dividend equivalents that will vest at the same time as the underlying Annual RSUs.
Mirrer Louise reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Louise Mirrer received additional stock-based compensation in the form of restricted stock units. On March 26, 2026, she was granted 20.07 "2025 Annual" RSUs and two "2024 Annual" RSU dividend-equivalent grants of 14.84 and 0.46 units.
Each RSU represents the right to receive one share of Moelis & Co Class A common stock. The 2024 and 2025 Annual RSUs were issued as dividend equivalents and will vest at the same time as the related underlying Annual RSU awards issued in 2024 and 2025. After these grants, reported holdings for these RSU awards are 1,731.7, 1,280.4 and 39.6 units, respectively.
The Vanguard Group filed Amendment No. 10 to Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Moelis & Co common stock. The filing explains an internal realignment effective January 12, 2026, that caused certain Vanguard subsidiaries or business divisions to report holdings separately in reliance on SEC Release No. 34-39538.
The amendment lists voting and dispositive powers as 0 and states that no single outside person holds more than 5% of the class. The form is signed by Ashley Grim as Head of Global Fund Administration.
Moelis & Company reports sharply stronger 2025 results, with revenue rising to $1,516.8 million from $1,194.5 million in 2024 and net income increasing to $259.6 million from $151.5 million. Operating margin improved as operating expenses fell to 82% of revenues, helped by higher average fees per completed transaction.
The firm advised 363 fee-paying clients in 2025, with 254 paying at least $1 million, and highlights over $5.5 trillion of transactions advised since inception and total stock return of about 506% since its IPO. It ended 2025 with $509.4 million in cash, $340.2 million in liquid investments, substantial regulatory capital, and zero debt.
Moelis paid dividends of $2.60 per share in 2025, declared a regular quarterly dividend of $0.65 per share for early 2026, and has board authorization to repurchase up to $301.5 million of Class A stock and partnership units. The firm continues to emphasize a capital‑light advisory model, global expansion, and internal talent development, with 1,416 employees and 178 Managing Directors as of early 2026.